This was the stock's second consecutive day of gains.

Despite decades of medical progress, HIV continues to devastate Black communities. The statistics are sobering. The disparities, undeniable.

Among its other ratings, Gilead's Accumulation/Distribution Rating of B shows moderate buying by institutional investors over ...

The largest group of Black physicians, thought leaders, and celebrities were in one room to have a needed discussion about HIV.

Over 60% of patients who received ervogastat plus clesacostat for 48 weeks achieved MASH resolution without fibrosis ...

Detailed price information for Pheton Holdings Ltd Cl A (PTHL-Q) from The Globe and Mail including charting and trades.

Gilead has a market-leading HIV franchise, led by flagship HIV therapies — Biktarvy and Descovy. Biktarvy sales and Descovy ...

Health Minister Aaron Motsoaledi told Bhekisisa’s TV show, Health Beat, in July, that he “would strongly consider” a ministerial advisory committee (MAC), like the one we had during the COVID pandemic ...

Why an HIV patient advocacy group is suing the Trump administration over a Biden administration legal settlement with Gilead ...

Cosmetics company e.l.f. Beauty (NYSE:ELF) will be reporting results this Wednesday afternoon. Here’s what investors should ...

The Dow opened 73.68 points higher on Tuesday, extending solid gains recorded in the previous session as US stocks rebounded ...